Literature DB >> 19534533

The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.

Miriam Gochin1, Lifeng Cai.   

Abstract

The hydrophobic pocket within the coiled coil domain of HIV-1 gp41 is considered to be a hot-spot suitable for small molecule intervention of fusion, although so far it has yielded only microM inhibitors. Previous peptide studies have identified specific hydrophobic interactions and a Lys-Asp salt bridge as contributing to binding affinity in the pocket. Negative charge appears to be critical for activity of small molecules. We have examined the role of charge and amphiphilic character in the interaction by studying a series of short pocket binding peptides differing in charge, helical content, and in the presence or absence of the Lys-Asp salt bridge, and a series of fatty acid salts with varying charge and hydrocarbon length. Quantitative binding analysis revealed that long-range electrostatic forces and a greasy nonspecific hydrophobic interaction were sufficient for microM potency. The results suggest that an extended interaction site may be necessary for higher potency. We examined a region of the coiled coil immediately C-terminal to the pocket and found that specific salt bridge and hydrogen bond networks may reside in this region. Negatively charged groups extended toward or beyond the C-terminus of the pocket could therefore result in improved low molecular weight fusion inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19534533      PMCID: PMC2724993          DOI: 10.1021/jm900190q

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  40 in total

1.  A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.

Authors:  S Jiang; A K Debnath
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

2.  Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop.

Authors:  M Caffrey
Journal:  Biochim Biophys Acta       Date:  2001-05-31

3.  Cooperative helix stabilization by complex Arg-Glu salt bridges.

Authors:  C A Olson; E J Spek; Z Shi; A Vologodskii; N R Kallenbach
Journal:  Proteins       Date:  2001-08-01

4.  Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells.

Authors:  Akira Otaka; Miki Nakamura; Daisuke Nameki; Eiichi Kodama; Susumu Uchiyama; Syota Nakamura; Hiroaki Nakano; Hirokazu Tamamura; Yuji Kobayashi; Masao Matsuoka; Nobutaka Fujii
Journal:  Angew Chem Int Ed Engl       Date:  2002-08-16       Impact factor: 15.336

5.  HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.

Authors:  S A Gallo; A Puri; R Blumenthal
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

6.  Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment.

Authors:  J Bestman-Smith; J Piret; A Désormeaux; M J Tremblay; R F Omar; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

7.  Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.

Authors:  F C Krebs; S R Miller; B J Catalone; P A Welsh; D Malamud; M K Howett; B Wigdahl
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

8.  Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.

Authors:  Shilong Wang; Joanne York; Wei Shu; Marisa O Stoller; Jack H Nunberg; Min Lu
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

9.  Thermodynamics of peptide inhibitor binding to HIV-1 gp41.

Authors:  J L Cole; V M Garsky
Journal:  Biochemistry       Date:  2001-05-15       Impact factor: 3.162

10.  Stable extended human immunodeficiency virus type 1 gp41 coiled coil as an effective target in an assay for high-affinity fusion inhibitors.

Authors:  Lifeng Cai; Edina Balogh; Miriam Gochin
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

View more
  17 in total

Review 1.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

2.  Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function.

Authors:  Dirk Eggink; Ilja Bontjer; Johannes P M Langedijk; Ben Berkhout; Rogier W Sanders
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  A suite of modular fluorescence assays interrogate the human immunodeficiency virus glycoprotein-41 coiled coil and assist in determining binding mechanism of low molecular weight fusion inhibitors.

Authors:  Miriam Gochin
Journal:  Assay Drug Dev Technol       Date:  2012-08-16       Impact factor: 1.738

4.  Swapped-domain constructs of the glycoprotein-41 ectodomain are potent inhibitors of HIV infection.

Authors:  Shidong Chu; Hardeep Kaur; Ariana Nemati; Joseph D Walsh; Vivian Partida; Shao-Qing Zhang; Miriam Gochin
Journal:  ACS Chem Biol       Date:  2015-02-17       Impact factor: 5.100

5.  Broad distribution of energetically important contacts across an extended protein interface.

Authors:  Lisa M Johnson; W Seth Horne; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2011-06-14       Impact factor: 15.419

6.  Origins of resistance to the HIVgp41 viral entry inhibitor T20.

Authors:  Brian E McGillick; Trent E Balius; Sudipto Mukherjee; Robert C Rizzo
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

Review 7.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

8.  Enhanced potency of bivalent small molecule gp41 inhibitors.

Authors:  Vladimir Sofiyev; Hardeep Kaur; Beth A Snyder; Priscilla A Hogan; Roger G Ptak; Peter Hwang; Miriam Gochin
Journal:  Bioorg Med Chem       Date:  2016-11-19       Impact factor: 3.641

Review 9.  Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides.

Authors:  Avraham Ashkenazi; Yechiel Shai
Journal:  Eur Biophys J       Date:  2011-01-22       Impact factor: 1.733

10.  NMR-assisted computational studies of peptidomimetic inhibitors bound in the hydrophobic pocket of HIV-1 glycoprotein 41.

Authors:  Miriam Gochin; Landon R Whitby; Aaron H Phillips; Dale L Boger
Journal:  J Comput Aided Mol Des       Date:  2013-07-27       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.